Lexaria Bioscience (CSE: LXX) Focus Seemingly on R&D as Licensing Revenues Slow: May. 7, 2019: Lexaria Bioscience (CSE: LXX) Landmark Partnership with Tobacco Titan: Feb. 5, 2019: Lexaria (CSE: LXX) Additional Licensees and Expanded IP: Aug. 31, 2018: Lexaria (OTCQX: LXRP / CSE: LXX) Initial Cannabis Focus; Multi-Market Potential: Jan. 12, 2018
Financials. View the latest financials. Balance SheetIncome StatementCash Flow. Email Alerts. Tear Sheet. Contacts. RSS News Feed. Lexaria Bioscience Corp. (CSE:LXX; OTCQX:LXRP) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules.
Percy and goddesses lemon fanfiction wattpad
Itunes for pc win 10 64 bit
Rutracker danaher